- Home
- Publications
- Publication Search
- Publication Details
Title
Using genomics to guide treatment for glioblastoma
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2018-09-11
DOI
10.2217/pgs-2018-0078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- The multiforme of glioblastoma
- (2018) Farshad Nassiri et al. NEURO-ONCOLOGY
- FGFR1actionable mutations, molecular specificities, and outcome of adult midline gliomas
- (2018) Alberto Picca et al. NEUROLOGY
- Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
- (2018) Janeta Popovici-Muller et al. ACS Medicinal Chemistry Letters
- Single-Cell RNA-Sequencing in Glioma
- (2018) Eli Johnson et al. Current Oncology Reports
- Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
- (2018) David Tamborero et al. Genome Medicine
- Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
- (2017) Martin J van den Bent et al. LANCET
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Spatial heterogeneity in medulloblastoma
- (2017) A Sorana Morrissy et al. NATURE GENETICS
- EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
- (2017) Faizaan Mohammad et al. NATURE MEDICINE
- PATH-08. THE PROGNOSTIC VALUE OF A NOVEL QUANTITATIVE MGMT PROMOTER METHYLATION SCORE FOR PATIENTS WITH GLIOBLASTOMA
- (2017) Akshay Ravi et al. NEURO-ONCOLOGY
- OS01.5 Development of TERT-targeting therapy using eribulin mesylate in mouse glioblastoma model
- (2017) M. Takahashi et al. NEURO-ONCOLOGY
- Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma
- (2017) Tatenda Mahlokozera et al. NEURO-ONCOLOGY
- Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
- (2017) Tobias Kessler et al. NEURO-ONCOLOGY
- Clonal expansion and epigenetic reprogramming following deletion or amplification of mutantIDH1
- (2017) Tali Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effect of Molecular Diagnostics on the Treatment of Glioma
- (2017) Nancy Ann Oberheim Bush et al. Current Oncology Reports
- Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive Cohort
- (2017) Yu Nakagawa et al. World Neurosurgery
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
- (2017) Spyros Darmanis et al. Cell Reports
- Genetic and epigenetic stability of oligodendrogliomas at recurrence
- (2017) Koki Aihara et al. Acta Neuropathologica Communications
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
- (2016) Angela Zacher et al. BRAIN PATHOLOGY
- Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients
- (2016) Deborah T. Blumenthal et al. JOURNAL OF NEURO-ONCOLOGY
- Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF‐ and EGF‐driven gliomas
- (2016) Sören Müller et al. Molecular Systems Biology
- Next-generation sequencing of central nervous systems tumors: the future of personalized patient management
- (2016) Leomar Y. Ballester et al. NEURO-ONCOLOGY
- Big data visualization identifies the multidimensional molecular landscape of human gliomas
- (2016) Hamid Bolouri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
- (2016) Carl Koschmann et al. Science Translational Medicine
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
- (2015) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Integrated genomic characterization of IDH1-mutant glioma malignant progression
- (2015) Hanwen Bai et al. NATURE GENETICS
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Toward precision medicine in glioblastoma: the promise and the challenges
- (2015) Michael D. Prados et al. NEURO-ONCOLOGY
- Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
- (2015) Marina N. Nikiforova et al. NEURO-ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- The NF1 gene revisited – from bench to bedside
- (2015) Yoon-Sim Yap et al. Oncotarget
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
- (2014) Kelly M. MacArthur et al. CANCER RESEARCH
- A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001
- (2014) Deborah T. Blumenthal et al. International Journal of Clinical Oncology
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
- (2014) Aden Ka-Yin Chan et al. MODERN PATHOLOGY
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Hematogenous dissemination of glioblastoma multiforme
- (2014) C. Muller et al. Science Translational Medicine
- Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
- (2014) J. P. Sullivan et al. Cancer Discovery
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
- (2013) Xiang Wang et al. ANNALS OF SURGICAL ONCOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Targeting the PDGF signaling pathway in tumor treatment
- (2013) Carl-Henrik Heldin Cell Communication and Signaling
- Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients
- (2013) Guo-Bin Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
- (2013) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110
- (2013) A. Schulte et al. NEURO-ONCOLOGY
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
- (2013) Lynn Bjerke et al. Cancer Discovery
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g
- (2012) Véronique Quillien et al. CANCER
- Sensitivity of Glioblastomas to Clinically Available MEK Inhibitors Is Defined by Neurofibromin 1 Deficiency
- (2012) W. L. See et al. CANCER RESEARCH
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- PDGF and PDGF receptors in glioma
- (2012) Inga Nazarenko et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
- (2012) Igor Vivanco et al. Cancer Discovery
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeted Therapy for BRAFV600E Malignant Astrocytoma
- (2011) T. P. Nicolaides et al. CLINICAL CANCER RESEARCH
- Rapid Radiographic and Clinical Improvement After Treatment of a MET-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor
- (2011) Andrew S. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
- (2010) Brock C. Christensen et al. JNCI-Journal of the National Cancer Institute
- Scientific correspondence
- (2010) S. Pusch et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
- (2009) Cameron Brennan et al. PLoS One
- Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers
- (2008) Stephen Yip et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now